Daewon Pharmaceutical Co., Ltd. (KRX:003220)
South Korea · Delayed Price · Currency is KRW 12,540
+40 (0.32%)
At close: Dec 5, 2025
Daewon Pharmaceutical Market Cap
Daewon Pharmaceutical has a market cap or net worth of 268.78 billion as of December 5, 2025. Its market cap has decreased by -12.73% in one year.
Market Cap
268.78B
Enterprise Value
421.66B
Revenue
590.70B
Ranking
n/a
PE Ratio
n/a
Stock Price
12,540.00
Market Cap Chart
Since March 1, 2001, Daewon Pharmaceutical's market cap has increased from 18.06B to 268.78B, an increase of 1,388.24%. That is a compound annual growth rate of 11.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 268.78B | -12.00% |
| Dec 30, 2024 | 305.43B | -7.98% |
| Dec 28, 2023 | 331.93B | -15.58% |
| Dec 29, 2022 | 393.20B | 14.64% |
| Dec 30, 2021 | 343.00B | -9.91% |
| Dec 30, 2020 | 380.71B | 13.65% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 75.96T |
| Celltrion | 40.11T |
| ALTEOGEN | 24.41T |
| ABL Bio | 10.51T |
| SK Biopharmaceuticals | 10.49T |
| Yuhan | 8.76T |
| LigaChem Biosciences | 6.75T |
| Peptron | 6.65T |